Seneschal Advisors
GH icon

Seneschal Advisors’s Guardant Health GH Stock Holding History

Seneschal Advisors’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$179 Buy
+1
New +$163 ﹤0.01% 585

Other funds holding GH

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $71.4B AUM 33.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Seneschal Advisors's GH Position: Q3 2026 in Review

Seneschal Advisors opened a new position in Guardant Health (GH) in Q3 2026: 1 share worth $179. The stake represents ﹤0.01% of the portfolio and ranks #585 among its holdings.

511 funds tracked by Wall St. Rank hold GH as of Q3 2026.

  • Seneschal Advisors held 1 share of Guardant Health worth $179 as of Q3 2026.
  • Guardant Health was a new Seneschal Advisors position in Q3 2026.
  • Guardant Health made up ﹤0.01% of Seneschal Advisors's portfolio in Q3 2026, its #585 holding.
  • 511 funds tracked by Wall St. Rank held Guardant Health as of Q3 2026.

Based on Seneschal Advisors's 13F filing for Q3 2026, filed 13 Nov 2026.